156 related articles for article (PubMed ID: 35429339)
1. Scrutinising the role of simvastatin in a patient of Pachyonychia Congenita with KRT6A gene mutation.
Sharma S; Dayal S; Aggarwal K; Gowda V M V; Kaur R
Australas J Dermatol; 2022 May; 63(2):e145-e149. PubMed ID: 35429339
[TBL] [Abstract][Full Text] [Related]
2. Pachyonychia congenita: a case report of a successful treatment with rosuvastatin in a patient with a KRT6A mutation.
Abdollahimajd F; Rajabi F; Shahidi-Dadras M; Saket S; Youssefian L; Vahidnezhad H; Uitto J
Br J Dermatol; 2019 Sep; 181(3):584-586. PubMed ID: 30307612
[TBL] [Abstract][Full Text] [Related]
3. Pathophysiology of pachyonychia congenita-associated palmoplantar keratoderma: new insights into skin epithelial homeostasis and avenues for treatment.
Zieman AG; Coulombe PA
Br J Dermatol; 2020 Mar; 182(3):564-573. PubMed ID: 31021398
[TBL] [Abstract][Full Text] [Related]
4. Thick nails, plantar keratoderma, follicular hyperkeratosis, and leukokeratosis associated with a novel mutation in KRT6A gene.
Tous-Romero F; Vico-Alonso C; Calleja-Algarra A; Sánchez-Calvín MT; Palencia-Pérez S
Int J Dermatol; 2019 Apr; 58(4):E89-E90. PubMed ID: 30515758
[No Abstract] [Full Text] [Related]
5. Two novel de novo mutations of KRT6A and KRT16 genes in two Chinese pachyonychia congenita pedigrees with fissured tongue or diffuse plantar keratoderma.
Du ZF; Xu CM; Zhao Y; Liu WT; Chen XL; Chen CY; Fang H; Ke HP; Zhang XN
Eur J Dermatol; 2012; 22(4):476-80. PubMed ID: 22668561
[TBL] [Abstract][Full Text] [Related]
6. Generalized bullae in a young girl with KRT6A-related pachyonychia congenita.
Liu J; Zhong W; Yu B; Lin Z; Zheng Y; Hu X
Pediatr Dermatol; 2020 Sep; 37(5):974-976. PubMed ID: 32662074
[TBL] [Abstract][Full Text] [Related]
7. A KRT6A mutation p.Ile462Asn in a Chinese family with pachyonychia congenita, and identification of maternal mosaicism: a case report.
Li Y; Wang Y; Ming Y; Chaolan P; Jia Z; Cheng N; Qiaoyu C; Li M; Tianyi X
BMC Med Genomics; 2021 Nov; 14(1):259. PubMed ID: 34724947
[TBL] [Abstract][Full Text] [Related]
8. A large mutational study in pachyonychia congenita.
Wilson NJ; Leachman SA; Hansen CD; McMullan AC; Milstone LM; Schwartz ME; McLean WH; Hull PR; Smith FJ
J Invest Dermatol; 2011 May; 131(5):1018-24. PubMed ID: 21326300
[TBL] [Abstract][Full Text] [Related]
9. Pachyonychia Congenita: A Spectrum of KRT6a Mutations in Australian Patients.
Forrest CE; Casey G; Mordaunt DA; Thompson EM; Gordon L
Pediatr Dermatol; 2016 May; 33(3):337-42. PubMed ID: 27041546
[TBL] [Abstract][Full Text] [Related]
10. A novel H1 mutation in keratin 6a in an infant with pachyonychia congenita.
Luo S; Luo Q; Zhang H; Wan C
Indian J Dermatol Venereol Leprol; 2015; 81(4):385-7. PubMed ID: 26087092
[TBL] [Abstract][Full Text] [Related]
11. A review of the clinical phenotype of 254 patients with genetically confirmed pachyonychia congenita.
Eliason MJ; Leachman SA; Feng BJ; Schwartz ME; Hansen CD
J Am Acad Dermatol; 2012 Oct; 67(4):680-6. PubMed ID: 22264670
[TBL] [Abstract][Full Text] [Related]
12. Walking a day in a pachyonychia congenita patient's shoes: Impact on plantar pain and activity levels measured with wristband activity trackers.
Lipner SR; Falotico JM; Matushansky JT; Evans H; Schwartz J; Hansen CD
Indian J Dermatol Venereol Leprol; 2023; 89(6):850-853. PubMed ID: 37317732
[TBL] [Abstract][Full Text] [Related]
13. Symptomatic mucosal involvement in pachyonychia congenita: challenges in infants and young children.
Goldberg I; Mashiah J; Kutz A; Derowe A; Warshauer E; Schwartz ME; Smith F; Sprecher E; Hansen CD
Br J Dermatol; 2020 Mar; 182(3):708-713. PubMed ID: 31777952
[TBL] [Abstract][Full Text] [Related]
14. Genotype-phenotype correlations of neurovascular structures on the feet in patients with pachyonychia congenita: A cross-sectional study.
Tan XL; Thomas BR; Steele L; Schwartz J; Hansen CD; O'Toole EA
J Am Acad Dermatol; 2022 Nov; 87(5):1172-1174. PubMed ID: 35245567
[No Abstract] [Full Text] [Related]
15. Revisiting pachyonychia congenita: a case-cohort study of 815 patients.
Samuelov L; Smith FJD; Hansen CD; Sprecher E
Br J Dermatol; 2020 Mar; 182(3):738-746. PubMed ID: 31823354
[TBL] [Abstract][Full Text] [Related]
16. Identification of clinically useful predictive genetic variants in pachyonychia congenita.
Samuelov L; Sarig O; Adir N; Pavlovsky M; Smith FJ; Schwartz J; Hansen CD; Sprecher E
Clin Exp Dermatol; 2021 Jul; 46(5):867-873. PubMed ID: 33486795
[TBL] [Abstract][Full Text] [Related]
17. Pachyonychia congenita patients with mutations in KRT6A have more extensive disease compared with patients who have mutations in KRT16.
Spaunhurst KM; Hogendorf AM; Smith FJ; Lingala B; Schwartz ME; Cywinska-Bernas A; Zeman KJ; Tang JY
Br J Dermatol; 2012 Apr; 166(4):875-8. PubMed ID: 22098151
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of botulinum toxin in pachyonychia congenita type 1: report of two new cases.
González-Ramos J; Sendagorta-Cudós E; González-López G; Mayor-Ibarguren A; Feltes-Ochoa R; Herranz-Pinto P
Dermatol Ther; 2016; 29(1):32-6. PubMed ID: 26445325
[TBL] [Abstract][Full Text] [Related]
19. First case of pachyonychia congenita in the Czech Republic.
Jiráková A; Rajská L; Rob F; Džambová M; Sečníková Z; Göpfertová D; Schwartz M; Smith F; Lotti T; Hercogová J
Dermatol Ther; 2015; 28(1):10-2. PubMed ID: 25174302
[TBL] [Abstract][Full Text] [Related]
20. Sexual Dimorphism in Response to an NRF2 Inducer in a Model for Pachyonychia Congenita.
Kerns ML; Hakim JMC; Zieman A; Lu RG; Coulombe PA
J Invest Dermatol; 2018 May; 138(5):1094-1100. PubMed ID: 29277538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
